Pulmonary valve stenosis is a heart condition where the pulmonary valve, which controls blood flow from the right side of your heart to your lungs, is too narrow. This forces the heart to work harder to push blood through, and over time that extra effort can strain the right ventricle. It accounts for 8% to 12% of all congenital heart disease cases, making it one of the more common heart defects present at birth.
How It Affects Blood Flow
Your heart’s right ventricle pumps oxygen-poor blood through the pulmonary valve and into the pulmonary artery, which carries it to the lungs to pick up oxygen. When the pulmonary valve is narrowed, the right ventricle has to generate more pressure to force blood through the smaller opening. Think of it like squeezing water through a kinked garden hose: the pump works harder, but less gets through.
Over months and years, this extra workload causes the muscular wall of the right ventricle to thicken. That thickening (called hypertrophy) can eventually make the chamber stiffer and less efficient at pumping. In severe cases, the right side of the heart can fail to keep up, leading to a backup of blood in the veins and symptoms like swelling in the legs and abdomen.
What Causes It
The vast majority of cases are congenital, meaning the valve didn’t form correctly during fetal development. In most people, no specific cause is ever identified. A study of 119 patients with pulmonary valve stenosis found that only 18% had a confirmed genetic diagnosis, and of those, 14% had Noonan syndrome or a closely related disorder. Noonan syndrome is the genetic condition most strongly linked to this defect, but it still explains a minority of cases.
Some people develop a form with a “dysplastic” valve, where the valve leaflets are unusually thick and stiff rather than simply fused together. This distinction matters because dysplastic valves respond differently to treatment. Rarely, pulmonary valve stenosis can develop later in life from conditions like rheumatic heart disease or tumors pressing on the valve, but acquired cases are uncommon.
Symptoms by Severity
Mild pulmonary valve stenosis often causes no symptoms at all. Many people live for decades without knowing they have it, and it’s discovered incidentally when a doctor hears a heart murmur during a routine exam. That murmur, a whooshing sound caused by turbulent blood flow through the narrow valve, is frequently the first clue.
As the narrowing becomes moderate or severe, symptoms tend to emerge. These can include shortness of breath during physical activity, fatigue that seems out of proportion to the effort, chest pain, and lightheadedness or fainting. In newborns with critical stenosis, the restricted blood flow to the lungs can cause cyanosis, a bluish tint to the skin and lips from low oxygen levels. Infants may also feed poorly and fail to gain weight normally.
How It’s Diagnosed
An echocardiogram (heart ultrasound) is the primary tool for both confirming the diagnosis and measuring its severity. The test uses sound waves to visualize the valve and measure how fast blood is moving through it. Faster flow means a tighter valve, because blood accelerates as it’s squeezed through a smaller opening.
Doctors classify severity based on the pressure difference (gradient) across the valve:
- Mild: pressure gradient below 36 mmHg, with blood velocity under 3 m/s
- Moderate: pressure gradient between 36 and 64 mmHg, with blood velocity between 3 and 4 m/s
- Severe: pressure gradient above 64 mmHg, with blood velocity over 4 m/s
These numbers reflect how hard the right ventricle is straining. A higher gradient means the heart is generating significantly more pressure than normal to move blood through the valve. In some cases, cardiac MRI or CT imaging is used to get a more detailed look at the valve anatomy, especially when planning a procedure.
Treatment: Balloon Valvuloplasty
Mild stenosis typically doesn’t require treatment, just periodic monitoring with echocardiograms to make sure it isn’t worsening. For moderate to severe cases, the standard treatment since the early 1980s has been balloon valvuloplasty, a catheter-based procedure that has largely replaced open-heart surgery for most patients.
During the procedure, a thin catheter with a deflated balloon at its tip is threaded through a vein in the groin and guided into the heart. The balloon is positioned across the narrowed pulmonary valve and inflated for a few seconds, stretching the valve open. It’s then deflated and removed. The entire process is done without opening the chest, and the entry site in the groin is closed with simple pressure.
The results are consistently strong. In studies of adolescents and adults, the pressure gradient across the valve dropped from an average of 91 mmHg before the procedure to 38 mmHg immediately after. At follow-up catheterization, gradients continued to improve, falling to around 30 mmHg. These results hold up over the long term and are comparable to what’s seen in young children who undergo the same procedure.
The one situation where balloon valvuloplasty works poorly is in patients with dysplastic valves. Because the valve tissue is thickened and rigid rather than fused, simply stretching it with a balloon doesn’t achieve a lasting result. These patients typically need surgical repair or valve replacement.
When Surgery Is Needed
Surgical valve replacement becomes necessary when catheter-based approaches aren’t feasible or haven’t worked. This includes patients with dysplastic valves, those who develop significant valve leakage (regurgitation) after a prior procedure, or those with complex anatomy that makes catheter access difficult.
Transcatheter valve replacement, where a new valve is delivered through a catheter rather than through open surgery, has become the preferred approach whenever the anatomy allows it. CT imaging plays a critical role in determining candidacy by mapping the valve’s position relative to nearby structures like the coronary arteries and sternum. When the anatomy isn’t suitable for a catheter-based replacement, traditional open-heart surgery remains effective.
Long-Term Outlook
After successful treatment, more than 90% of patients remain free of complications over the long term. That said, the most common issue after valve intervention is pulmonary valve regurgitation, where the valve that was stretched open now leaks. This occurs in roughly one-third of treated patients and can eventually lead to right ventricular enlargement from handling the extra blood volume.
A large long-term study with a median follow-up of 13.5 years found that patients diagnosed with pulmonary stenosis had a higher overall mortality rate compared to the general population, with a 4.67 times greater risk of death. However, this elevated risk was concentrated almost entirely in patients diagnosed during the first year of life, who had a nearly 11 times greater mortality risk. Those diagnosed between ages 1 and 10, or after age 10, showed no excess risk compared to matched controls. Cardiac-related causes accounted for about half of the deaths in the stenosis group.
For most people with pulmonary valve stenosis, particularly those with mild disease or those successfully treated in childhood, the condition is very manageable. Regular follow-up with a cardiologist remains important, since changes like progressive valve leakage or right ventricular stiffness can develop gradually over years and may eventually need attention.